Esperance Pharmaceuticals Overview

  • Year Founded
  • 2005

Year Founded

  • Status
  • Out of Business

  • Employees
  • 11

Employees

  • Latest Deal Type
  • Out of Business

Esperance Pharmaceuticals General Information

Description

Operator of a biotechnology company intended to develop targeted anti-cancer drugs that selectively kill cancer cells without harming the normal cells. The company's drugs seek and destroy dividing and non-dividing cancer cells including cells known to be resistant to chemotherapeutics, enabling medical practitioners with drugs that kill cancer cells by a novel mechanism of action by disrupting their cell membranes leading to cell lysis.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 909 Fannin Street
  • Suite 2000
  • Houston, TX 77010
  • United States
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Corporate Office
  • 909 Fannin Street
  • Suite 2000
  • Houston, TX 77010
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Esperance Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Out of Business 19-Nov-2024 Completed Out of Business
7. Secondary Transaction - Private 01-Jul-2021 Completed Pre-Clinical Trials
6. Later Stage VC 11-Jul-2019 Completed Pre-Clinical Trials
5. Later Stage VC (Series C) 30-Mar-2016 Completed Pre-Clinical Trials
4. Later Stage VC (Series B) 01-Jun-2011 Completed Pre-Clinical Trials
3. Early Stage VC (Series A1) 09-Feb-2009 Completed Pre-Clinical Trials
2. Early Stage VC 24-Nov-2008 $3.2M $12.2M Completed Pre-Clinical Trials
1. Early Stage VC (Series A) 18-Oct-2006 $9M $9M Completed Pre-Clinical Trials
To view Esperance Pharmaceuticals’s complete valuation and funding history, request access »

Esperance Pharmaceuticals Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B
Series A1
Series A 9,000,000 $0.001000 8% $1 $1 1x $1 9.02%
To view Esperance Pharmaceuticals’s complete cap table history, request access »

Esperance Pharmaceuticals Patents

Esperance Pharmaceuticals Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2021195553-A1 Lytic domain fusion constructs, checkpoint inhibitors, and methods of making and using same Inactive 26-Mar-2020
AU-2013344701-A1 Follicle-stimulating hormone (fsh)/lytic domain fusion constructs and methods of making and using same Inactive 15-Nov-2012
CA-2910311-A1 Follicle-stimulating hormone (fsh)/lytic domain fusion constructs and methods of making and using same Inactive 15-Nov-2012
EP-2920212-A1 Follicle-stimulating hormone (fsh)/lytic domain fusion constructs and methods of making and using same Inactive 15-Nov-2012
EP-2920212-A4 Follicle-stimulating hormone (fsh)/lytic domain fusion constructs and methods of making and using same Inactive 15-Nov-2012 C07K14/59
To view Esperance Pharmaceuticals’s complete patent history, request access »

Esperance Pharmaceuticals Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Esperance Pharmaceuticals FAQs

  • When was Esperance Pharmaceuticals founded?

    Esperance Pharmaceuticals was founded in 2005.

  • Where is Esperance Pharmaceuticals headquartered?

    Esperance Pharmaceuticals is headquartered in Houston, TX.

  • What is the size of Esperance Pharmaceuticals?

    Esperance Pharmaceuticals has 11 total employees.

  • What industry is Esperance Pharmaceuticals in?

    Esperance Pharmaceuticals’s primary industry is Drug Discovery.

  • Is Esperance Pharmaceuticals a private or public company?

    Esperance Pharmaceuticals is a Private company.

  • What is Esperance Pharmaceuticals’s current revenue?

    The current revenue for Esperance Pharmaceuticals is .

  • How much funding has Esperance Pharmaceuticals raised over time?

    Esperance Pharmaceuticals has raised $84.9M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process